admin – Page 6820 – Get News Story

Blue Atlas Marketing Unveils New Social Media Strategies to Enhance Trade Show Success

The newly released “How to Leverage Social Media Marketing for Trade Shows” offers businesses a robust blueprint for amplifying their trade show presence, driving traffic, and fostering lasting connections.

Houston, Texas – April 17, 2024 – Blue Atlas Marketing introduces its groundbreaking strategy for leveraging social media to enhance trade show outcomes. The newly released “How to Leverage Social Media Marketing for Trade Shows” offers businesses a robust blueprint for amplifying their trade show presence, driving traffic, and fostering lasting connections.

Blue Atlas Marketing’s strategy emerges as a vital tool for businesses aiming to stand out in an era where digital presence significantly impacts trade show success. “Trade shows offer a golden opportunity for direct engagement and brand showcasing, yet the real challenge lies in capturing and maintaining attendee interest in a crowded marketplace. Our approach leverages social media not just as a promotional tool but as an extension of the trade show experience itself,” explains Alana Wells Maresh, Programming Manager at Blue Atlas Marketing. The strategy outlined in the guide emphasizes a three-phase approach—Pre-Show Buzz Building, In-Show Engagement, and Post-Show Connection—to ensure holistic and impactful trade show participation.

A key takeaway from the article highlights the importance of targeted audience engagement and platform selection, underscoring the need for tailored content that resonates with potential visitors’ preferences and behaviors. “Knowing your audience and where they spend their digital time is crucial. Whether it’s LinkedIn for professional networking or Instagram and Facebook for visual storytelling, selecting the right platforms is the first step towards creating a buzz that draws trade show attendees to your booth,” Maresh adds.

The strategy also explores the power of real-time engagement during trade shows, advocating live updates, interactive elements like polls and Q&A sessions, and strategic content scheduling to keep the audience engaged and informed. Post-show strategies focus on capitalizing on the event’s momentum, using social media to share highlights, engage with leads, and foster growth from the connections made.

As businesses navigate the complexities of trade show marketing, Blue Atlas Marketing’s vision serves as a beacon, illuminating the path to capturing attendees attention and converting that interest into meaningful business opportunities. With a blend of strategic insights, actionable tips, and real-world applications, the guide positions businesses to leverage the full potential of social media in their trade show endeavors.

Blue Atlas Marketing has again set the benchmark for innovative marketing strategies with its latest initiative focused on maximizing trade show success through social media. This groundbreaking approach comes as a response to the evolving dynamics of trade show marketing, where digital presence has become just as pivotal as the physical. The unveiling of this strategy not only celebrates Blue Atlas Marketing’s long-standing commitment to cutting-edge marketing solutions but also reinforces its position as a thought leader in the digital marketing realm, dedicated to empowering businesses to achieve their full potential in the competitive trade show landscape.

About Blue Atlas Marketing

With its unwavering commitment to innovation and results-driven strategies, Blue Atlas Marketing stands at the forefront of digital marketing excellence. Specializing in a comprehensive suite of services from SEO and web design to social media management, Blue Atlas empowers businesses to achieve their marketing objectives and navigate the digital landscape confidently.

For more information on how Blue Atlas can transform your digital marketing efforts, visit https://www.blueatlasmarketing.com/

Media Contact
Company Name: Blue Atlas Marketing
Contact Person: Nathaniel Stockard
Email: Send Email
Phone: 713-244-6643
Address:11601 Shadow Creek Parkway Ste 111-372
City: Pearland
State: TX
Country: United States
Website: https://www.blueatlasmarketing.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Blue Atlas Marketing Unveils New Social Media Strategies to Enhance Trade Show Success

Dumpit Scotland Offers Compassionate and Efficient Probate Property Clearance Services in Glasgow

discussing of the Probate clearance service

Glasgow, Scotland – April 17, 2024 – Dumpit Scotland, a leading provider of waste removal and clearance services, understands the sensitive nature of probate property clearances. The company offers compassionate and efficient solutions to help families and executors navigate this often-difficult process.

“We recognise that dealing with the belongings of a loved one can be emotionally overwhelming,” said Rory Friel, Contact at Dumpit Scotland. “Our probate property clearance service is designed to ease the burden, handling everything with respect and care while ensuring a thorough and timely clearance.”

Dumpit Scotland’s probate property clearance services Glasgow include:

Full or Partial Clearances: Tailored to your needs, whether it’s removing specific items or clearing an entire property.

Responsible Disposal: Prioritizing donation, recycling, and eco-conscious disposal methods to honor the belongings and minimize environmental impact.

Sensitive Handling: The team understands the emotional significance and treats all items with care and respect.

Flexible Scheduling: Accommodating your timeline and working around any necessary legal processes.

Clear Communication: Providing transparent updates and support throughout the clearance process

Probate property clearance company in Glasgow

About Dumpit Scotland

Dumpit Scotland is a Glasgow-based company with over 15 years of experience in property clearance and waste removal. We are committed to providing compassionate and professional services, especially during challenging times such as probate clearances.

Media Contact
Company Name: Dumpit Scotland
Contact Person: Rory Friel
Email: Send Email
Phone: 0141 258 1707
Address:50 East Kilbride Road
City: Glasgow
Country: Scotland
Website: www.dumpitscotland.co.uk/commercial/probate-property-clearance-services-glasgow/

Introducing Dice Provisions: Pioneering New Dimensions in Culinary Innovation

Dice Provisions, a visionary food innovation company based in Los Angeles, proudly announces its emergence onto the culinary scene.

With a mission to enhance life’s simple pleasures through innovative twists on beloved foods, Dice Provisions is poised to revolutionize the way individuals experience culinary delights.

Crafted by a team of seasoned brand marketers and experts in the F&B and CPG industries, Dice Provisions firmly believes that innovation should enrich, rather than overshadow, the delight of savoring staple culinary classics. With a dedicated team of food enthusiasts, they strive to create products that elevate daily experiences and enhance life’s simple pleasures.

Dice Provisions embarks on an exciting journey, thrilled to offer a sneak peek into their inaugural creation: Dice Coffee Cubes. With a commitment to redefining the coffee experience, Dice Coffee Cubes promise to transform morning rituals (or evening rendezvous) into flavorful adventures.

Crafted from premium organic coffee and designed to preserve the integrity of brews, Dice Coffee Cubes are poised to revolutionize the way individuals enjoy their favorite beverages. Stay tuned as Dice Provisions prepares to unveil this innovative product, set to redefine coffee routines and elevate mornings to new heights.

Join Dice Provisions as they set out on this gastronomic journey and get ready to savor the unexpected. For more information and updates, visit DiceProvisions.com and follow on social media @diceprovisions.

About Dice Provisions

Dice Provisions, a portfolio company of Good Mood Ventures LLC, is a Los Angeles-based food innovation company dedicated to reinventing the art of culinary indulgence. They craft novel twists on beloved foods to elevate life’s simple pleasures, fueled by a passion for creativity and a commitment to quality. Dice Provisions is redefining the boundaries of flavor and delighting taste buds around the world.

Media Contact
Company Name: Dice Provisions | Good Mood Ventures
Email: Send Email
Country: United States
Website: https://www.diceprovisions.com/

New Spacecraft Projects Utilizing Advanced Solar Technology; Partnership between Ascent Solar Technologies, Inc (NASDAQ: ASTI) & Momentus (NASDAQ: MNTS)

• Leading Provider of Innovative, High-Performance, Flexible Thin-Film Solar Panel Technology.

• Specific Applications in Environments Mass, Performance, Reliability, and Resilience are Key Considerations.

• 40 years of R&D, 15 years Manufacturing, Numerous Awards, and a Comprehensive IP and Patent Portfolio.

• Products Used in Space Missions, Aircraft, Agrivoltaic Installations, in Industrial/Commercial Construction and Extensive Consumer Goods. `

• New Partnership with Momentus Bring to Market Leading-Edge Solar Arrays.

• 2024 Public Offering Launched for up to $6 Million Cash Infusion.

• Thin Film CIGS Technology Reached Record Power Generation of 14 Watts at Production Scale with Thin Film.

• Substantial Debt Reduction and Plan for Full Payoff.

Ascent Solar Technologies, Inc (NASDAQ: ASTI) is backed by 40 years of R&D, 15 years of manufacturing experience, numerous awards, and a comprehensive IP and patent portfolio. ASTI is a leading provider of innovative, high-performance, flexible thin-film solar panels for use in environments where mass, performance, reliability, and resilience matter. ASTI photovoltaic (PV) modules have been deployed on space missions, multiple airborne vehicles, agrivoltaic installations, in industrial/commercial construction as well as an extensive range of consumer goods, revolutionizing the use cases and environments for solar power. The ASTI research and development center and 5-MW nameplate production facility is strategically located in Thornton, Colorado.

Momentus Partnership Will Bring to Market Leading-Edge Solar Arrays

On April 17th ASTI and Momentus Inc. (NASDAQ: MNTS) announced a new partnership to jointly market leading-edge solar arrays utilizing the low-cost Tape Spring Solar Array (TASSA) being developed by Momentus and the high performance of the ASTI flexible, lightweight photovoltaic modules.

The rapid growth in the production and deployment of thousands of satellites in space has led to the burgeoning need for low-cost, reliable solar arrays with high performance. Momentus plans to add a high-power photovoltaic array as a differentiated feature of the next iteration of the TASSA product under development. Last year’s pathfinder TASSA mission demonstration validated solar blankets from ASTI as a mass efficient and robust power generation solution. Momentus plans to incorporate in TASSA new higher efficiency solar blankets from ASTI composed of space industry optimized Titan Modules, providing even lower cost per kW of power.

ASTI Announces Pricing of Public Offering for up to $6 Million Cash Infusion

On April 10th ASTI announced the launch of a “best efforts” public offering of gross proceeds up to $6 million at a price of $0.14 per share of common stock. In lieu of Shares, investors can purchase one prefunded warrant to purchase a Share. The prefunded warrants are immediately exercisable at a price of $0.0001 per Share and only expire when such prefunded warrants are fully exercised. Dawson James Securities, Inc. is acting as the exclusive placement agent for the offering.

CIGS Technology Power Generation Milestones at Production Scale with Thin Film

On Match 25th ASTI announced that its thin film CIGS technology reached record power generation of 14 watts at production scale.

Since the installation of new leadership in April 2023, ASTI engineering and production teams have focused on improving their processes and chemical formulation, resulting in continuous increases in power generated from its innovative thin-film PV. The first in a series of milestones was initially announced on September 5, 2023, with subsequent improvements shared at regular intervals.

Using the AST Titan™ module to illustrate improvement, CIGS technology has steadily increased its power generation capabilities over the past seven months. The ASTI Titan™ module is approximately one square foot in size with a thickness of 0.03mm and a weight of just over eight grams.

Below are the recent calculations for power generation* at ASTI Titan™ module dimensions:

• September 15, 2023
11.6 watts

• October 30, 2023
13.1 watts

• November 16, 2023
13.3 watts

• March 20, 2024
14.0 watts

Note: Power generation figures reflect STC conditions and AM0

ASTI anticipates reaching its next milestone of 16 watts output for the Titan™ module in the near term. The increases in power generation for its CIGS PV technology align with ASTI strategy and revenue goals for 3rd and 4th quarters 2024 and 2025, meeting the technological needs for ASTI customers in space to achieve end of life power.

Substantial Debt Reduction and Plan for Full Payoff

On March 21st ASTI provided a corporate update on the Securities Purchase Contract with two institutional investors previously disclosed on December 19, 2022.

It was reported that one institutional investor’s notes payable and related liabilities have been completely paid out and the remaining investor has been substantially paid off with an approximate remaining notes payable balance of $6,700 and an approximate $200,000 of payables outstanding. It is ASTI management’s intention to pay all remaining balances with this institutional investor upon completion of the next equity raise.

For more information on $ASTI visit https://www.ascentsolar.com

DISCLAIMER: https://corporateads.com/disclaimer/

All Disclosures listed on the on www.corporateads.com

Media Contact
Company Name: Ascent Solar Technologies, Inc
Contact Person: Paul Warley, President and CEO
Email: Send Email
Phone: (720) 872-5000
Address:12300 Grant Street
City: Thornton
State: Colorado 80241
Country: United States
Website: https://ascentsolar.com/

Bestqool proves the effectiveness and safety of its red light therapy device with a professional third-party Report

Bestqool, a well-reputed manufacturer of red light therapy devices with a vision of helping people achieve a healthier lifestyle, has proudly announced the results of a comprehensive third-party report confirming the effectiveness and safety of its red light therapy devices.

Bestqool’s product’s irradiance is tested and approved by LightLab International Allentown, LLC, a professional third-party testing agency in the United States that specializes in comprehensive assessment of irradiance and other parameters of red light therapy devices to ensure its quality, safety, and efficacy. Unlike other RLT companies, Bestqool doesn’t use solar meters to measure irradiance. Recently, LightLab International Allentown tested the Bestqool RLT device’s irradiance and reported devices to have a high-level irradiance (58-100 mW/cm²), which is very suitable for safe and effective deep tissue healing.

Red light therapy, scientifically known as photobiomodulation, is a type of cold light source nature-based phototherapy that augments body functions safely and non-invasively by irradiating the human body with concentrated wavelengths of red light and near-infrared light (660-850 nm). Bestqool, a leading manufacturer in the industry of red light therapy, offers lifestyle game-changing devices that prioritize safety, efficacy, and user comfort.

The utilization of red light therapy in well-being has its roots dating back to ancient Greek times. NASA began investigating the benefits of red light therapy initially in the 1970s by using it to grow plants in space. Medical research has shown that red light has a special biological effect on the human body, which can be absorbed by the mitochondria of cells. This light potentially activates the body cell’s energy and stimulates various enzymes in the mitochondria, thereby promoting antioxidant levels and improving the function of entire tissues and organs. The red light scope of therapy is diverse and impactful on well-being.

The red visible light band emitted by the RLT device can be absorbed by the mitochondria in the cells, which increases cell metabolism and regeneration.
Red light irradiation stimulates vasodilation and accelerates blood circulation. This helps to provide more nutrients and oxygen to the cells and promotes the elimination of waste and carbon dioxide by supporting detoxification.
Red light therapy can increase the phagocytosis of white blood cells and improve the immune function of the body. White blood cells are an important part of the body’s immune system, which can recognize and engulf pathogens such as bacteria and viruses, thus playing a role in fighting infection.
The RLT device can heal wounds and ulcers by stimulating the proliferation and differentiation of cells on the surface of the skin, accelerating the healing process of wounds, and reducing healing time and scar formation.

Recently, hundreds of clinical studies have been conducted to prove the efficacy of red light therapy. It is also famous for anti-aging, pain relieving, immunity boosting, and sleep-improving advantages. Unlike ultraviolet light, red light is harmless to the skin and does not tan or cause dark spots to the skin. Red light therapy’s common applications are the following:

Physical and mental well-being: weight loss, muscle toning, and mood and cognitive enhancement.
Dermatological diseases: herpes zoster, alopecia areata, lower limb ulcers, bedsores, phlebitis, erysipelas, boils, dermatitis, folliculitis, acne, paronychia, rosacea, anal itching, chilblains, and various genital warts.
Surgical diseases: wound infection, abscess, ulcer, prostatitis, lumbar muscle strain, anal fissure, frozen shoulder, soft tissue contusion, scalds, buttock induration after injection, burns, and post-operative healing.

One of the crucial factors that the reader needs to pay attention to when buying red light therapy is RLT device irradiance. Irradiance is the amount of power delivered per square centimeter of body area per second, commonly expressed as mW/cm²/s (milliwatts per square cm). Irradiance contributes directly to the effectiveness and outcomes of red light therapy.

Treatment Depth and Efficacy

Light with different wavelengths and irradiation parameters has specific depths of action on cells, particularly mitochondria in the body. High irradiance levels deliver a deeper amount of light energy to cells, while low irradiance targets the superficial layer of skin.

Irradiance	Dosage	Uses
Low irradiance	5-20 mW/cm²	Acne, dermatitis, minor wounds
Medium irradiance	20-50 mW/cm²	Wrinkles, scars, deep tissue injuries
High irradiance	50–100 mW/cm²	Joint pain, muscle injuries, chronic inflammation

Optimum Dosage Selection

The proper dose of red light therapy is determined by irradiance along with wavelength and duration of treatment, which is necessary for effective treatment. Low, medium, and high irradiance can be utilized according to the treatment goals.

Equipment Safety

Many companies rely on solar power meters for red light therapy device irradiance measurement in the red light therapy industry, which has led to overstated results. Solar meters lack the precision to test red light therapy-specific wavelengths, potentially resulting in misleading therapy dosage calculations. Don’t choose equipment that is not tested and approved by a professional third-party organization to prevent ineffective and risky treatments.

Bestqool’s product philosophy is “Stronger, better.” It uses rigorous testing methods for product safety to deliver a high level of therapy that is hard to find in any other at-home red light therapy device. Bestqool red light therapy equipment’s core technology offers these unparalleled features:

Upgraded and durable LEDs

Dual chip high-energy light emitting diodes (LEDs) with reasonable and stable output intensity. The therapeutic dose is accurate, and the life is long.

Deep Concentrated Wavelengths

Clinically proven most effective wavelengths from visible spectrum red light 660 nm, near-infrared light 850 nm.

Certification

Cleared by FDA, CE, FCC, and ETL

Safe and Effective

Bestqool offers comfortable medical-grade, non-invasive, non-ablative, non-burning therapy. Tested by LightLab International Allentown, LLC, a third party, for user safety, quality, and reliability.

Conclusion

Given the backdrop of innovation, safety, and efficacy in the red light therapy field, it’s reasonable to conclude that Bestqool and Joovv stand out as premier brands in this field. Both companies prioritize the use of advanced technology, rigorous testing, and certification to ensure the highest standards of quality and effectiveness in their products. Bestqool never-ending quest for better health is committed to bringing more advanced red light therapy health solutions in the future. Remember, red light therapy devices are not a substitute for professional medical treatment to cure diseases. RLT helps people who are medically powerless and want to relieve physical and mental discomfort. Appropriate usage of red light therapy can improve visual health, mood, sleep, cognition, and work efficiency to ensure high quality of life.

Youtube: https://www.youtube.com/@bestqooltherapy

Instgram: https://www.instagram.com/bestqool/

TK: https://www.tiktok.com/@bestqool

Reference and Citations

[1] Glass G. E. (2021). Photobiomodulation: The Clinical Applications of Low-Level Light Therapy. Aesthetic surgery journal, 41(6), 723–738. https://doi.org/10.1093/asj/sjab025

[2] Jagdeo, J., Nguyen, J. K., Ho, D., Wang, E. B., Austin, E., Mamalis, A., Kaur, R., Kraeva, E., Schulman, J. M., Li, C. S., Hwang, S. T., Wun, T., Maverakis, E., & Isseroff, R. R. (2020). Safety of light emitting diode-red light on human skin: Two randomized controlled trials. Journal of biophotonics, 13(3), e201960014. https://doi.org/10.1002/jbio.201960014

[3] Zhu, Q., Cao, X., Zhang, Y., Zhou, Y., Zhang, J., Zhang, X., Zhu, Y., & Xue, L. (2023). Repeated Low-Level Red-Light Therapy for Controlling Onset and Progression of Myopia-a Review. International journal of medical sciences, 20(10), 1363–1376. https://doi.org/10.7150/ijms.85746

[4] Li, W. H., Seo, I., Kim, B., Fassih, A., Southall, M. D., & Parsa, R. (2021). Low-level red plus near infrared lights combination induces expressions of collagen and elastin in human skin in vitro. International journal of cosmetic science, 43(3), 311–320. https://doi.org/10.1111/ics.12698

[5] DE Oliveira, M. F., Johnson, D. S., Demchak, T., Tomazoni, S. S., & Leal-Junior, E. C. (2022). Low-intensity LASER and LED (photobiomodulation therapy) for pain control of the most common musculoskeletal conditions. European journal of physical and rehabilitation medicine, 58(2), 282–289. https://doi.org/10.23736/S1973-9087.21.07236-1

Media Contact
Company Name: Bestqool
Contact Person: Rachel He
Email: Send Email
Country: United States
Website: https://www.bestqool.com/

Little Gem Tours Offers Exclusive Private Tour Experiences in Ireland

Discover Ireland’s hidden charms with Little Gem’s customized private tours.

Little Gem Tours, a distinguished private tour operator based in Ireland, invites travelers to explore the captivating beauty of the country through personalized and private tours. With a commitment to providing unique experiences away from the typical tourist routes, Little Gem Tours offers bespoke itineraries tailored to the preferences of each traveler.

Recognized as the Private Tour Operator of the Year in 2018/2019, 2020 & 2024 by esteemed organizations such as the Luxury Travel Guide and The Travel and Hospitality Awards, Little Gem Tours is renowned for its exceptional service and dedication to crafting authentic Irish experiences.

As an Irish family owned and run business the founders of Little Gem Tours, express their gratitude to visitors, emphasizing their commitment to combining unique itineraries with the expertise of experienced driver guides and a selection of boutique accommodations to ensure an unforgettable journey through their homeland – Ireland.

Specializing in multi-day escorted, private tours covering the length and breadth of Ireland, Little Gem Tours offers a diverse range of experiences to suit every traveler’s preferences. Whether exploring the rugged coastline of the Wild Atlantic Way or delving into Ireland’s rich cultural heritage, or connecting to roots through Irish ancestry tours, travelers can customize their itinerary to create a truly memorable adventure.

For more information about Little Gem Tours and its customizable private tour packages, visit https://www.littlegemtours.com/ now. Discover the hidden gems of Ireland with Little Gem Tours and embark on a journey unlike any other.

About Little Gem Tours

Little Gem Tours is a renowned private tour operator in Ireland, offering bespoke travel experiences away from the crowds. Recognized as the Private Tour Operator of the Year multiple times, the company specializes in crafting unique itineraries tailored to travelers’ preferences, ensuring an authentic exploration of Ireland’s hidden charms.

Media Contact
Company Name: Little Gem Tours
Contact Person: Robbie McGrane
Email: Send Email
Phone: +353860474836
Country: Ireland
Website: https://www.littlegemtours.com/

Animalia disrupts the U.S. pet insurance market

Firms like Animalia.pet are behind the recent boom in U.S. pet insurance – and why more and more Americans are realizing pet insurance isn’t a luxury – it’s a necessity.

Ron R., the proud dog dad of a Great Dane named Thor, faced the worst-case scenario any pet parent fears – a life-threatening medical emergency. Thor had gastric dilatation-volvulus, commonly known as “bloat,” which can develop without warning and prove fatal if left untreated.

It’s the kind of medical emergency that most people tell themselves won’t happen to them… until it does. The truth is far, far different. Statistics show that every dog will suffer 6 significant health episodes in their lifetime, with each incident costing an average of $1,100.

That’s enough to put most families in a hole that would be hard to climb out of by themselves. Luckily, these days pet insurance means people don’t have to do it themselves. Insurance providers like Animalia.pet give dog and cat owners the peace of mind that if something like what happened to Thor happens to them, they’ll be able to give their pets the best care possible.

That’s precisely what Animalia delivers – taking the financial component out of decision-making when pet health is concerned. What sets Animalia apart, however, is holistic care. Not only is emergency care in cases of accident or illness included in their coverage, but so are behavioral therapy (with licensed vets), alternative care (like acupuncture), prescription food, and televet services.

Yoni Kiehl, Animalia CEO and founder, underlines the difference. “The basic principle was, and still is,” he explains, “care-based and not cost-based.”

According to NAPHIA (North American Pet Health Insurance Association), in 2023, 5.67 million American pets were insured – an uptick of 17.1% compared to 2022. That’s not a one-off, either. Growth in this metric has been observed every single year since 2019.

And with good reason. Technological and scientific advancements in pet healthcare have gone hand-in-hand with rising costs. That’s exactly where insurance comes on. The owners of a Doberman Pinscher from Fredericksburg, VA were especially lucky to have Animalia’s coverage when their dog ate a foreign body and needed surgery. Animalia paid out $6,950, so they could provide their dog with the best care available.

The industry as a whole is booming, but Animalia is proving to be a breed apart, giving pet owners the peace of mind that should anything go wrong, they won’t go it alone.

Visit http://www.animalia.pet/

Media Contact
Company Name: Animalia
Contact Person: Noa Lifshitz
Email: Send Email
Phone: 1-888-719-4629
Country: United States
Website: https://animalia.pet/

Noticias Blockchain Among the First to Launch of Blockchain for Good Alliance (BGA) at Blockchain Life Dubai

Noticias Blockchain is a premier Spanish blockchain news portal helmed by tech-savvy highly experienced journalists specializing in cryptocurrencies and blockchain technologies. The company recently published a comprehensive coverage of BGA’s launch.

The world of cryptocurrencies and blockchain technologies expands at a rapid pace, witnessing breakthroughs big and small on a seemingly daily basis. To ensure that traders, crypto-curious individuals, investors, and blockchain experts across the globe have instant access to reliable news, Noticias Blockchain offers its services.

Noticias Blockchain is a Spain-based news portal specializing in all things crypto and blockchain. From major cryptocurrencies and altcoins to De-Fi, Web3, and recent advances in blockchain technologies, Noticias Blockchain’s experts cover every piece of information that emerges in this ever-growing digital space.

Knowing that speedy delivery of unbiased information is crucial to professional crypto traders, investors, and business owners, Noticias Blockchain has its expert journalist teams on the field seeking verifiable news around the clock. The firm was among the first to report on the historic launch of Blockchain for Good Alliance (BGA) at Blockchain Life Dubai – a non-profit collaborative project seeking to uplift societal well-being by harnessing blockchain-based technologies into tackling major problems across the globe.

The team at Noticias Blockchain underscores that some of the biggest names in the crypto world came together to form an unshakeable foundation for the future of blockchain. Bybit Web3, Harvard Blockchain Club, Solana Foundation, Moledao, Edu3Labs, University of Sharjah, Libera, ICP.Hub UAE, Alchemy Pay, and numerous other high-profile organizations partnered to spearhead innovation and progress, as well as to make technological advances more equitable, reports Noticias Blockchain.

Beyond extensively covering all the recent key events in the blockchain industry, this company is continuously searching for the latest mainstream happenings in the Bitcoin world, or as Spanish news reporters dub it, “Noticias Bitcoin”.

Major cryptos are steadily gaining traction, much to the delight of traders and investors everywhere. Noticias Blockchain reports that Polkadot marked significant growth of close to 10% in recent days; the Shibarium universe is witnessing gains between 4-6% while Bitcoin is still in the lead, albeit its growth is slightly humbler relative to the previous months.

Apart from news articles and publications, Noticias Blockchain strives to ensure its content is easily digestible to newcomers. The company’s crypto experts have embedded a streamlined list of current prices for Bitcoin, Ethereum, Tether, Binance Coin, Solana, and several other dominating cryptocurrencies complete with graphical representations and actual prices in EUR.

The list is routinely updated every 24 hours and delivers accurate crypto pricing information to all visitors of the leading Spanish blockchain-focused news portal.

Knowing that cryptocurrencies are widely popular among business owners hailing from all branches and niches, the team at Noticias Blockchain has expanded their repertoire to interviews with business owners, experts, coaches, and prominent figures who are globally recognized as prime movers.

Among countless featured articles in the Business Noticias field, a few have garnered substantial popularity and have helped many readers gain insights into business dynamics.

The business department of Noticias Blockchain has covered all key events that transpired in April 2024. From an upsurge in retail sales in the US to follow-ups in legal court battles renowned businessmen have been locked in for months to the latest news in the AI space, this innovative news portal is bringing up-to-date details concerning all the most impactful moments in the international business industry.

In addition to researching and analyzing the works of some of the brightest minds in Europe, the US, Asia, and beyond, the team at Noticias Blockchain also strives to educate their readers by providing valuable tips by renowned experts.

One of their most recent publications reads “Small Business Basics: Expert Advice from a Startup Owner”, an interview with Elias Stahl, CEO and co-founder of Oregon-based company HILOS. This and many similar interviews by Noticias Blockchain dive deep into the stories, habits, struggles, and accomplishments forward-thinking business owners wear on their sleeves, helping countless budding entrepreneurs and SME owners learn how to efficiently pursue success.

More information about Noticias Blockchain is available on the company’s official website.

Media Contact
Company Name: Noticias Blockchain
Contact Person: Ignacio
Email: Send Email
Country: Spain
Website: https://noticias-blockchain.com

New Data on Infection Avoidance and Development of pH Neutral Ketamine, for Intravenous and Subcutaneous Use: NRx Pharmaceuticals (Nasdaq: NRXP)

• Developing Therapeutics for the Treatment of CNS Disorders, Specifically Suicidal Bipolar Depression, Chronic Pain and PTSD.

• MOU Signed with Conversio Health with Immediate Plans to Ship IV Ketamine Product to Full Range of Customers via 503a and 503b Pharmacies.

• No Impact on Gut or Vaginal Flora – Considered Primary Causes of Pseudomembranous Colitis due to C Difficile and Vaginal Yeast Infections.

• Received FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation in Complicated Urinary Tract Infection (cUTI) and Pyelonephritis.

• Achieved pH Neutral Formulation of Ketamine, Potentially Enabling Both Intravenous (IV) and Subcutaneous (SQ) Administration.

• Data-Lock Achieved in Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression as needed to Unlock Partner Funding.

• Study Maintained 95% Concordance Rate Between Study Sites and Central Raters on Primary Endpoint. No Unexpected Serious Adverse Events Reported.

• Positive Sata and FDA Comment Triggers $5 Million Payment from Partners Alvogen and Lotus and their Assumption of Development Costs with up to $330 Million in Milestone Payments and a Royalty on Net Sales in the Mid-Teens.

• Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRXP Shareholders.

• Received $5 Million Milestone Payment from Partners Alvogen, Inc. and Lotus Pharmaceutical Co. Ltd. (1975.TW)

• NRXP Eligible for Additional $324 Million in Development & Sales Milestones, Plus Double-Digit Royalties Upon Approval and Commercialization of NRX-101.

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. NRXP is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRXP has partnered with Alvogen Pharmaceuticals around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRXP has recently announced plans to submit a New Drug Application for NRX-100 (IV ketamine) in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRXP was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

New Data Demonstrating No Damage to Internal Flora in Validated Models Compared to Standard Antibiotics: Value to Avoidance of Infections

On April 17th NRXP announced new data that demonstrate that in a rodent model, the Company’s NRX-101 shows no measurable damage to either intestinal or vaginal flora, compared to the significant negative effect caused by drugs such as ciprofloxacin. Antibiotics commonly used to treat complicated urinary tract infections (cUTI) are associated with pseudomembranous colitis caused by Clostridium difficile (C diff) and vaginal yeast infections, primarily owing to their impact on normal flora.

Whereas most antibiotics have substantial effect in the large bowel, the key component of the NRXP drug NRX-101 (D-cycloserine) is entirely absorbed in the small intestine and excreted unmetabolized in the urine. If the nonclinical data reported today are replicated in patients, The NRXP NRX-101 could represent the first antibiotic for cUTI and pyelonephritis that has essentially no risk of causing C. diff infection or vaginal yeast infection. There is an extensive literature surrounding the use of D-cycloserine to treat tuberculosis and cases of C. Diff are unknown. D-cycloserine’s effect as an antibiotic is based on its propensity to substitute for the amino acid alanine in the formation of the bacterial cell wall.

“While we have primarily focused on NRX-101 as a drug to treat CNS disease, these new and highly provocative findings suggest that NRX-101 could find a home as a first line treatment for cUTI and pyelonephritis, which afflicts more than 3 million Americans each year. Should the rodent model findings prove applicable to the people, the use of NRX-101 to treat cUTI without increasing the risk of C. diff infection could have multibillion dollar potential,” said Stephen Willard, JD, Chief Executive Officer of NRXP.

The NRXP NRX-101 has received FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation in Complicated Urinary Tract Infection (cUTI) and Pyelonephritis.

Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)

On April 15th NRXP announced that the Company has developed a novel, proprietary formulation of IV Ketamine for use as HTX-100. This new NRXP formulation has the key advantage of achieving neutral pH, in contrast to the acidic pH of generic formulations of ketamine. Acidic substances are tolerated when diluted for intravenous use, but cause pain and may cause skin ulcers if administered subcutaneously. This patentable NRXP invention may enable the administration of ketamine in insulin pump-like devices in the clinic setting, eliminating the requirement for intravenous infusion personnel. NeuroRx, Inc. previously executed a joint development agreement with a manufacturer of insulin pumps but has been awaiting a suitable, pH neutral formulation of ketamine.

With this proprietary formulation, developed with partner Nephron Pharmaceuticals, a leading sterile products manufacturer, NRXP is expected to generate one or more patents, such as composition of matter or formulation.

Data-Lock Achieved in Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

On April 8th NRXP announced achieving data-lock in its Phase 2b/3 Suicidal Treatment Resistant Bipolar Depression Study with NRX-101. With data-lock the complete data set passed on for statistical analysis; top-line data release expected in April 2024.

With positive data from this study and FDA comment, NRXP becomes eligible to receive the balance of its first milestone (an additional $4 million) from partners Alvogen, Inc. and Lotus Pharmaceuticals, Inc. (1745.TW). These partners would then be responsible for all future development costs in this indication. NRXP retains rights for all other indications, including chronic pain and PTSD. NRXP is then poised to receive $320 million in further milestones along with mid-teen royalties on Net Sales.

Fourth Quarter and Full Year 2023 Financial Results Plus Business Update

On April 1, 2024 NRXP announced its fourth quarter results and provided a recap of recent key business developments. These included four potential near-term milestones, including data from two clinical trials, an NDA filing and an upcoming share dividend. Additional accomplishments covered in the announcement were as follows:

NRXP delivered a 50% reduction in corporate overhead and 25% reduction in overall net loss in 2023, compared to 2024 with $0.20 per share improvement in negative earnings. Additions to working capital of $8 million in Q1 2024.

NRXP forecasts first commercial revenue in 2024 from sales of ketamine and related technologies. Company received advance of first milestone payments in 2024 for ongoing development of NRX-101 from Alvogen and Lotus Pharmaceuticals, Inc. (1975.TW)

NRXP announced new partnership around the first drug to potentially modify the underlying cause of schizophrenia

Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders

On March 18th NRXP announced that its Board of Directors has authorized its Chairman and management to take all necessary steps to affect a Dividend of HOPE Therapeutics (“HOPE”) stock along with a royalty right of 1% of Ketamine sales to NRXP Shareholders and applicable warrant holders. The intent of NRXP is to distribute 49% of HOPE stock in this dividend. Shares of HOPE are planned to be publicly listed.

For more information on $NRXP visit: https://www.nrxpharma.com/ and https://axecapitalusa.com/nrxp/

DISCLAIMER: https://corporateads.com/disclaimer/

Disclosure listed on the on the CorporateAds website

Media Contact
Company Name: NRx Pharmaceuticals, Inc.
Contact Person: Jonathan Javitt, Founder of $NRXP
Email: Send Email
Phone: 484 254 6134
Address:1201 Orange Street Suite 600
City: Wilmington
State: Delaware 19801
Country: United States
Website: https://www.nrxpharma.com/

Stephanie Wilson Team at Keller Williams Realty Earns Luxury Designation in South Carolina and North Carolina

SPARTANBURG, SC – April 17, 2024 – The Stephanie Wilson Team, a prominent Spartanburg SC realtor that operates and licensed in South Carolina and North Carolina under Keller Williams Realty, is thrilled to announce that it recently earned the designation as a luxury agency. This recognition underscores the team’s unwavering commitment to delivering unparalleled service, expertise, and tailored solutions to clients seeking upscale properties in the SC and NC regions while also catering to all the real estate needs of their clients in the said areas.

With a solid foundation built on trust, integrity, and market insight, the Stephanie Wilson Team has consistently set industry standards, earning a reputation for excellence in the real estate market. Their capability to handle upscale transactions further solidifies their position as leaders in the region’s real estate sector, offering clients access to exclusive listings, exceptional marketing strategies, and personalized concierge services tailored to meet the unique needs and expectations of all homebuyers and sellers.

“As experienced agents from Keller Williams Realty, we are honored to have earned the prestigious designation,” said Stephanie Wilson, Team Leader. “It reflects our team’s dedication to providing exceptional service and our deep understanding of the entire real estate market in SC and NC. We are committed to exceeding our clients’ expectations and delivering unparalleled results.”

In addition, the Stephanie Wilson Team is excited to announce the expansion of their team with the addition of new, talented, and experienced team members. These new additions bring fresh perspectives, diverse skill sets, and a shared passion for real estate, further enhancing the team’s capabilities and ensuring clients receive the highest level of service and support throughout their real estate journey.

“The addition of our new team members marks an exciting chapter for the Stephanie Wilson Team,” added Stephanie Wilson. “With their expertise and our collective drive, we are confident that we will continue to raise the bar in real estate and achieve even greater success for our clients.”

As things start to come together for the Stephanie Wilson Team, they remain steadfast in their commitment to serving both states’ communities and helping clients turn their real estate dreams into reality. Whether you are buying or selling any type of property, the Stephanie Wilson Team is here to guide you every step of the way with professionalism, dedication, and a personalized approach that sets them apart in the industry.

About the Stephanie Wilson Team

The Stephanie Wilson Team | Keller Williams Realty in South Carolina, stands as a beacon of excellence in the region’s real estate market. Renowned for their unwavering commitment to client satisfaction, integrity, and market expertise, the team has recently earned the prestigious designation as a luxury agency. Composed of seasoned professionals, the Stephanie Wilson Team offers personalized, concierge-level service tailored to meet the unique needs of all homebuyers and sellers. With a deep understanding of the local market, the Stephanie Wilson Team is dedicated to helping clients navigate the complexities of the real estate landscape with confidence and success.

For more information about the Stephanie Wilson Team and their luxury real estate services, please visit their website or contact them directly at 828.778.6222.

Media Contact
Company Name: Stephanie Wilson Team | Keller Williams Realty
Contact Person: Stephanie Wilson
Email: Send Email
Phone: 828-778-6222
Address:1707 John B White Sr Blvd
City: Spartanburg
State: SC 29301
Country: United States
Website: https://thestephaniewilsonteam.com/